litlas
Log inCreate account

Yasuhiro Shimada

Active 1984–2026

72
Papers
18,478
Citations
48
h-index
64
i10-index

Citations

Citations per year for Yasuhiro Shimada1984: 1 citations1989: 1 citations1991: 4 citations1992: 1 citations1993: 3 citations1994: 2 citations1995: 6 citations1996: 4 citations1997: 13 citations1998: 4 citations1999: 9 citations2000: 4 citations2001: 14 citations2002: 11 citations2003: 17 citations2004: 18 citations2005: 23 citations2006: 37 citations2007: 29 citations2008: 47 citations2009: 62 citations2010: 67 citations2011: 63 citations2012: 68 citations2013: 99 citations2014: 133 citations2015: 152 citations2016: 159 citations2017: 188 citations2018: 138 citations2019: 541 citations2020: 645 citations2021: 603 citations2022: 430 citations2023: 296 citations2024: 581 citations2025: 234 citations2026: 10 citations1985–1988: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,109 citing papers, 17.1% of this breakdownJapan: 1,053 citing papers, 16.2% of this breakdownChina: 673 citing papers, 10.4% of this breakdownItaly: 397 citing papers, 6.1% of this breakdownUnited Kingdom: 328 citing papers, 5.1% of this breakdownGermany: 288 citing papers, 4.4% of this breakdownFrance: 247 citing papers, 3.8% of this breakdownSouth Korea: 231 citing papers, 3.6% of this breakdownSpain: 230 citing papers, 3.6% of this breakdownNetherlands: 191 citing papers, 2.9% of this breakdownCanada: 156 citing papers, 2.4% of this breakdownSwitzerland: 118 citing papers, 1.8% of this breakdown
0%17.1%Other 22.6%

Institutions

Fields

  • Medicine72.4%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Materials Science7%
  • Neuroscience3.7%
  • Psychology1.7%
  • Computer Science1.4%
  • Other4.2%

Topics

  • Gastric Cancer Management and Outcomes8%
  • Colorectal Cancer Surgical Treatments6%
  • Colorectal Cancer Treatments and Studies5.9%
  • Gastrointestinal Tumor Research and Treatment3%
  • Nanoparticle-Based Drug Delivery2.9%
  • Neuroendocrine Tumor Research Advances2.8%
  • Other71.4%

Coauthors

All papers

Open in search
  1. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

    Authors: Yojiro Hashiguchi, Kei Muro, Yutaka Saitō, Yoshinori Ito, Yoichi Ajioka, Tetsuya Hamaguchi, Kiyoshi Hasegawa, Kinichi Hotta, Hideyuki Ishida, Megumi Ishiguro, Soichiro Ishihara, Yukihide Kanemitsu, Yusuke Kinugasa, Keiko Nemoto Murofushi, Takako Eguchi Nakajima, Shiro Oka, Toshiaki Tanaka, Hiroya Taniguchi, Akihito Tsuji, Keisuke Uehara, Hideki Ueno, Takeharu Yamanaka, Kentaro Yamazaki, Masahiro Yoshida, Takayuki Yoshino, Michio Itabashi, Kentaro Sakamaki, Keiji Sano, Yasuhiro Shimada, Shinji Tanaka, Hiroyuki Uetake, Shigeki Yamaguchi, Naohiko YAMAGUCHI, Hirotoshi Kobayashi, Keiji Matsuda, Kenjiro Kotake, Kenichi Sugihara, Japanese Society for Cancer of the Colon and Rectum - International Journal of Clinical Oncology 2019 cited by 1,958

  2. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

    Authors: H. Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, G. Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae‐You Kim, David Cunningham, Philippe Rougier, Yoshito Komatsu, Jaffer A. Ajani, Michael Emig, Roberto Carlesi, David Ferry, Kumari Chandrawansa, Jonathan D. Schwartz, Atsushi Ohtsu - The Lancet Oncology 2014 cited by 2,471

  3. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer

    Authors: Japanese Society for Cancer of the Colon and Rectum, Toshiaki Watanabe, Kei Muro, Yoichi Ajioka, Yojiro Hashiguchi, Yoshinori Ito, Yutaka Saito, Tetsuya Hamaguchi, Hideyuki Ishida, Megumi Ishiguro, Soichiro Ishihara, Yukihide Kanemitsu, Hiroshi Kawano, Yusuke Kinugasa, Norihiro Kokudo, Keiko Murofushi, Takako Eguchi Nakajima, Shiro Oka, Yoshiharu Sakai, Akihito Tsuji, Keisuke Uehara, Hideki Ueno, Kentaro Yamazaki, Masahiro Yoshida, Takayuki Yoshino, Narikazu Boku, Takahiro Fujimori, Michio Itabashi, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Yasuhiro Shimada, Keiichi Takahashi, Shinji Tanaka, Osamu Tsuruta, Toshiharu Yamaguchi, Naohiko YAMAGUCHI, Toshiaki Tanaka, Kenjiro Kotake, Kenichi Sugihara - International Journal of Clinical Oncology 2017 cited by 2,490

  4. Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    Authors: Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio García‐Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu, Alberto Sobrero, Éveline Boucher, Marc Peeters, Ben Tran, Heinz‐Josef Lenz, Alberto Zaniboni, Howard S. Höchster, James M. Cleary, Hans Prenen, Fabio Benedetti, Hirokazu Mizuguchi, Lukas Makris, Masanobu Ito, Atsushi Ohtsu - New England Journal of Medicine 2015 cited by 1,431

  5. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

    Authors: James C. Yao, Nicola Fazio, Simron Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiří Tomášek, Markus Raderer, Harald Lahner, Maurizio Voi, Lida Pacaud, Nicolas Rouyrre, Carolin Sachs, Juan W. Valle, Gianfranco Delle Fave, Eric Van Cutsem, Margot Tesselaar, Yasuhiro Shimada, Do‐Youn Oh, Jonathan Strosberg, Matthew H. Kulke, Marianne Pavel - The Lancet 2015 cited by 1,264

  6. A multi-site, multi-disorder resting-state magnetic resonance image database

    Authors: Saori Tanaka, Ayumu Yamashita, Noriaki Yahata, Takashi Itahashi, Giuseppe Lisi, Takashi Yamada, Naho Ichikawa, Masahiro Takamura, Yujiro Yoshihara, Akira Kunimatsu, Naohiro Okada, Ryuichiro Hashimoto, Go Okada, Yuki Sakai, Jun Morimoto, Jin Narumoto, Yasuhiro Shimada, Hiroaki Mano, Wako Yoshida, Ben Seymour, Takeshi Shimizu, Koichi Hosomi, Youichi Saitoh, Kiyoto Kasai, Nobumasa Kato, Hidehiko Takahashi, Yasumasa Okamoto, Okito Yamashita, Mitsuo Kawato, Hiroshi Imamizu - Scientific Data 2021 cited by 158

  7. Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial

    Authors: Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, Yoshitaka Inaba, Tetsuya Hamaguchi, Dai Shida, Masayuki Ohue, Koji Komori, Akio Shiomi, Manabu Shiozawa, Jun Watanabe, Takeshi Suto, Yusuke Kinugasa, Yasumasa Takii, Hiroyuki Bando, Takaya Kobatake, Masafumi Inomata, Yasuhiro Shimada, Hiroshi Katayama, Haruhiko Fukuda, on behalf of the JCOG Colorectal Cancer Study Group - Journal of Clinical Oncology 2021 cited by 219

  8. Harmonization of resting-state functional MRI data across multiple imaging sites via the separation of site differences into sampling bias and measurement bias

    Authors: Ayumu Yamashita, Noriaki Yahata, Takashi Itahashi, Giuseppe Lisi, Takashi Yamada, Naho Ichikawa, Masahiro Takamura, Yujiro Yoshihara, Akira Kunimatsu, Naohiro Okada, Hirotaka Yamagata, Koji Matsuo, Ryuichiro Hashimoto, Go Okada, Yuki Sakai, Jun Morimoto, Jin Narumoto, Yasuhiro Shimada, Kiyoto Kasai, Nobumasa Kato, Hidehiko Takahashi, Yasumasa Okamoto, Saori Tanaka, Mitsuo Kawato, Okito Yamashita, Hiroshi Imamizu - PLoS Biology 2019 cited by 210

  9. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer

    Authors: Japanese Society for Cancer of the Colon and Rectum, Toshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada, Shinji Tanaka, Yoshinori Ito, Yoichi Ajioka, Tetsuya Hamaguchi, Ichinosuke Hyodo, Masahiro Igarashi, Hideyuki Ishida, Megumi Ishiguro, Yukihide Kanemitsu, Norihiro Kokudo, Kei Muro, Atsushi Ochiai, Masahiko Oguchi, Yasuo Ohkura, Yutaka Saito, Yoshiharu Sakai, Hideki Ueno, Takayuki Yoshino, Takahiro Fujimori, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Keiichi Takahashi, Hiroya Takiuchi, Osamu Tsuruta, Toshiharu Yamaguchi, Masahiro Yoshida, Naohiko YAMAGUCHI, Kenjiro Kotake, Kenichi Sugihara - International Journal of Clinical Oncology 2011 cited by 713

  10. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial

    Authors: Yukihide Kanemitsu, Kohei Shitara, Junki Mizusawa, Tetsuya Hamaguchi, Dai Shida, Koji Komori, Satoshi Ikeda, Hitoshi Ojima, Hideyuki Ike, Akio Shiomi, Jun Watanabe, Yasumasa Takii, Takashi Yamaguchi, Kenji Katsumata, Masaaki Ito, Junji Okuda, Ryoji Hyakudomi, Yasuhiro Shimada, Hiroshi Katayama, Haruhiko Fukuda, JCOG Colorectal Cancer Study Group - Journal of Clinical Oncology 2021 cited by 198

  11. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

    Authors: Yasuhiro Matsumura, Tsuyoshi Hamaguchi, Takashi Ura, Kei Muro, Yasuhide Yamada, Yasuhiro Shimada, Kuniaki Shirao, Takuji Okusaka, Hideki Ueno, Masafumi Ikeda, Noriko Watanabe - British Journal of Cancer 2004 cited by 617

  12. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer

    Authors: Toshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada, Shinji Tanaka, Yoshinori Ito, Yoichi Ajioka, Tetsuya Hamaguchi, Ichinosuke Hyodo, Masahiro Igarashi, Hideyuki Ishida, Soichiro Ishihara, Megumi Ishiguro, Yukihide Kanemitsu, Norihiro Kokudo, Kei Muro, Atsushi Ochiai, Masahiko Oguchi, Yasuo Ohkura, Yutaka Saito, Yoshiharu Sakai, Hideki Ueno, Takayuki Yoshino, Narikazu Boku, Takahiro Fujimori, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Keiichi Takahashi, Osamu Tsuruta, Toshiharu Yamaguchi, Masahiro Yoshida, Naohiko YAMAGUCHI, Kenjiro Kotake, Kenichi Sugihara, Japanese Society for Cancer of the Colon and Rectum - International Journal of Clinical Oncology 2015 cited by 600

  13. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial

    Authors: Seigo Kitano, Masafumi Inomata, Junki Mizusawa, Hiroshi Katayama, Masahiko Watanabe, Seiichiro Yamamoto, Masaaki Ito, Shuji Saito, Shoichi Fujii, Fumio Konishi, Yoshihisa Saida, Hirotoshi Hasegawa, Tomonori Akagi, Kenichi Sugihara, Takashi Yamaguchi, Tadahiko Masaki, Yosuke Fukunaga, Kohei Murata, Masazumi Okajima, Yoshihiro Moriya, Yasuhiro Shimada - ˜The œLancet. Gastroenterology & hepatology 2017 cited by 302

  14. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

    Authors: Tsuyoshi Hamaguchi, Ken Kato, Hisateru Yasui, Chigusa Morizane, Masafumi Ikeda, Hideki Ueno, Kei Muro, Yasuhide Yamada, Takuji Okusaka, Kuniaki Shirao, Yasuhiro Shimada, Hiroko Nakahama, Yasuhiro Matsumura - British Journal of Cancer 2007 cited by 287

  15. Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma

    Authors: Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi, Yuji Negoro, Yasuhiro Shimada, Jun Iwata, Manabu Matsumoto, Yasuhiro Hata, Yoshihiro Noda, Kenta Sui, Taijiro Sueda - World Journal of Surgery 2018 cited by 94

  16. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version

    Authors: Toshirou Nishida, Seiichi Hirota, Akio Yanagisawa, Yoshinori Sugino, Manabu Minami, Yoshitaka Yamamura, Yoshihide Otani, Yasuhiro Shimada, Fumiaki Takahashi, Tetsuro Kubota - International Journal of Clinical Oncology 2008 cited by 352

  17. Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

    Authors: Yasuhiro Matsumura, Mitsukazu Gotoh, Kei Muro, Yasuhide Yamada, Kuniaki Shirao, Yasuhiro Shimada, Mayumi Okuwa, Shin Matsumoto, Yosihisa Miyata, H Ohkura, K. Chin, Shinichi Baba, Takekazu Yamao, Ayako Kannami, Yasuo Takamatsu, Kaori Ito, Kazunori Takahashi - Annals of Oncology 2004 cited by 253

  18. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer

    Authors: Ken Kato, Keisho Chìn, Takaki Yoshikawa, Kensei Yamaguchi, Yasushi Tsuji, Taito Esaki, Kenji Sakai, Masami Kimura, Tetsuya Hamaguchi, Yasuhiro Shimada, Yasuhiro Matsumura, Ryuji Ikeda - Investigational New Drugs 2011 cited by 235

  19. Role of Vertical Larynx Movement and Cervical Lordosis in F0 Control

    Authors: Kiyoshi Honda, Hiroyuki Hirai, Shinobu Masaki, Yasuhiro Shimada - Language and Speech 1999 cited by 165

  20. A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy

    Authors: Takako Yanai, Satoru Iwasa, Hironobu Hashimoto, Fumiyoshi Ohyanagi, Tomomi Takiguchi, Koji Takeda, Masahiko Nakao, Hiroshi Sakai, Toshiaki Nakayama, Koichi Minato, Takahiro Arai, Kenichi Suzuki, Yasuhiro Shimada, Kengo Nagashima, Hiroyuki Terakado, Noboru Yamamoto - International Journal of Clinical Oncology 2017 cited by 75

  21. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

    Authors: Takako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, Koh Furuta, Takuji Gotoda, Hitoshi Katai, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada - Journal of Gastroenterology 2009 cited by 179

  22. Plasma lipid peroxides and alpha-tocopherol in critically ill patients

    Authors: Kiyoshi Takeda, Yasuhiro Shimada, Masaru Amano, Toshiko Sakai, Toshiki Okada, Ikuto Yoshiya - Critical Care Medicine 1984 cited by 131

  23. The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006)

    Authors: Yasumasa Takii, Junki Mizusawa, Yukihide Kanemitsu, Koji Komori, Manabu Shiozawa, Masayuki Ohue, Satoshi Ikeda, Nobuhiro Takiguchi, Takaya Kobatake, Hideyuki Ike, Toshihiko Satō, Naohiro Tomita, Mituyoshi Ota, Tadahiko Masaki, Tetsuya Hamaguchi, Dai Shida, Hiroshi Katayama, Yasuhiro Shimada, Haruhiko Fukuda - Annals of Surgery 2021 cited by 35

  24. Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)

    Authors: Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, Narikazu Boku, Ichinosuke Hyodo, Hiroshi Saito, Noboru Yamamichi, Yoshinori Miyata, Nobumasa Ikeda, Seiichiro Yamamoto, Haruhiko Fukuda, Shigeaki Yoshida - Journal of Clinical Oncology 2002 cited by 431